Blood transcriptomics reveal persistent SARS-CoV-2 RNA and candidate biomarkers in Long COVID patients

A recent groundbreaking study titled “Blood transcriptomics reveal persistent SARS-CoV-2 RNA and candidate biomarkers in Long COVID patients” has shed new light on the complexities of Long COVID, a condition affecting an estimated 65 million individuals globally. This medRxiv preprint, authored by Soraya Maria Menezes, Marc Jamoulle, Maria Paula Carletto, and others, represents a significant stride in understanding and potentially managing Long COVID. The Study’s Core Findings: Methodology at a Glance: The study utilized blood transcriptomics to explore viral persistence and potential diagnostic biomarkers for Long COVID in a real-world, general practice-based setting. Long COVID patients, diagnosed according to WHO…